Last reviewed · How we verify

NCT04719728

Evaluate Audiological Outcome of Cochlear Implant Program in Sohag University Hospital

Status unknown Last updated 22 January 2021
What this trial tests

trial testing Aided pure tone audiometry in Hearing Loss, Sensorineural, Bilateral in 100 participants. Status unknown.

Timeline
1 March 2021
Primary endpoint
1 December 2021
1 March 2022

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 March 2021
Primary completion1 December 2021
Estimated completion1 March 2022

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 1 to 60, any sex, with Hearing Loss, Sensorineural, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the outcome of cochlear implantation (CI) is very important issue since adequate hearing is linked to improved communication outcomes and school performance, development of speech and language, enhances speech perception in quiet and noise and even allows CI recipients to use the telephone. As well as there is a growing need for a widely used set of international quality standards on minimal outcome measurements to determine outcomes in CI recipients, monitor the auditory progress of CI recipients over time and to be able to relate on important issues as the most ideal age for implantation and the cut-off audiological thresholds for CI indication. This study will be conducted to evaluate outcome of cochlear implantation in sohag university hospital. Aim of work: To evaluate the outcome of cochlear implantation in Sohag university hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04719728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing